Lymphoma (includes NHL, HL, CNS Lymphoma)
Latest Articles
(PharmaTimes [UK]) Feb 23, 2017 - Mundipharma is gearing up to launch biosimilar Truxima in seven European markets for the treatment of certain cancers and inflammatory conditions, after Celltrion bagged a regulatory approval for the drug.
Read Article
(labiotech.eu) Dec 6, 2016 - From leukemia to multiple myeloma, biotech is working hard to cure blood cancer. This year’s edition of the American Society of Hematology (ASH) annual meeting features immuno-oncology therapies developed by the best European biotechs, with Novartis taking the lead in the CAR-T field.
Read Article
More Articles
December 07, 2016
December 07, 2016
December 07, 2016
December 06, 2016
December 06, 2016
December 06, 2016
December 05, 2016
December 05, 2016
View More
News Commentary
Editor Image
26 Jun, 2016 | by William McGivney, PhD
This study is a game changer in providing data that supports stopping bleomycin...
View Comment
View More
OBR Green
There are no Lymphoma (includes NHL, HL, CNS Lymphoma) OBR Green articles.
OBR Blog
Introduction In an effort to provide you with timely market feedback from the 58th ASH Annual Meeting held in December... Read more
January 06, 2017
By: Greg Wolfe, Ph.D., Senior Consultant, Clinical & Scientific Assessment, Kantar Health and Jay Grisolano, Ph.D.,... Read more
December 07, 2016